- 1.30.2026
- Stanford Research
Men’s Journal: Study — New Psychedelic Drug Combo Improves PTSD
Reports on the mystical-experience paper, noting PTSD symptom reductions in 30 male veterans after magnesium–ibogaine treatment. It presents the findings as preliminary support for larger PTSD trials.
- 8.1.2025
- Stanford Research
Neurology Advisor: Magnesium–Ibogaine May Be Beneficial for Combat Veterans With TBI
Reports that magnesium–ibogaine may benefit combat veterans with TBI based on observed resting-state brain-wave changes. The piece focuses on altered cortical oscillations and links those signals to psychiatric and cognitive outcomes.
- 7.24.2025
- Stanford Research
News-Medical: Ibogaine treatment shows major breakthrough for veterans with brain injuries
Covers the Nature Mental Health paper on magnesium–ibogaine effects on cortical oscillations and neural complexity. It highlights the study as evidence that ibogaine may produce measurable brain-function changes in veterans with TBI.
- 7.22.2025
- Stanford Research
U.S. Medicine: Magnesium–Ibogaine Therapy Could Offer Treatment Option for TBI
Summarizes the Nature Mental Health study for a veteran/clinical audience, emphasizing rapid changes in brain activity after treatment. It includes comments from lead author Jennifer Lissemore about why the team studied ibogaine’s effects on brain function.
- 7.15.2025
- Stanford Research
Military.com: Veteran Executive Order a Win for Ibogaine, But More Research Needed
Mentions the newer MRI findings showing increased cortical thickness after magnesium–ibogaine treatment. It places the study in the context of veteran advocacy and the need for more rigorous ibogaine research.